Cargando…
327P COVID-19 in patients with oncohematologic diseases in Kazakhstan
Autores principales: | Dushimova, Z., Jazyltayeva, A., Nassipov, B., Gabbasova, S., Kemelbekov, N. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
European Society for Medical Oncology. Published by Elsevier Ltd.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7680618/ http://dx.doi.org/10.1016/j.annonc.2020.10.321 |
Ejemplares similares
-
PB1868: EXPERIENCE IN THE TREATMENT OF HAIRY CELL LEUKEMIA IN KAZAKHSTAN.
por: Kemelbekov, N., et al.
Publicado: (2022) -
323P Oncology care in the Republic of Kazakhstan during COVID-19
por: Kaidarova, D., et al.
Publicado: (2020) -
PB2584: EXPLOSIVE GROWTH ANTIMICROBIAL RESISTANCE IN CENTRAL KAZAKHSTAN IN ONCOHEMATOLOGICAL PATIENTS IN POST COVID PERIOD
por: Lyssenko, Angelina, et al.
Publicado: (2023) -
COVID-19 in Children and Adolescents: Characteristics and Specificities in Immunocompetent and Oncohematological Patients
por: Mercolini, Federico, et al.
Publicado: (2022) -
Identification of platelet refractoriness in oncohematologic patients
por: Ferreira, Aline Aparecida, et al.
Publicado: (2011)